Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol and etomidate mixture for deep sedation during gastrointestinal endoscopy
ChiCTR2400093109Phase 4Not yet recruiting
- Sponsor
- Zibo City Central Hospital
- Start
- Nov 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofol and etomidate in gastrointestinal conditions (3 arms), sponsored by Zibo City Central Hospital. Primary endpoint: Composite incidence of adverse events. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
ciprofoletomidate
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2400093109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093109.